Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ER-Positive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Not applicableStudy completedNCT03285568
What this trial is testing

Patterns of Prescribing and Monitoring of Palbociclib

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerEstrogen Receptor-positive Breast Cancer+1 more
Rush University Medical Center 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT01872260
What this trial is testing

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 259
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173556
What this trial is testing

A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Qilu Pharmaceutical Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT05896566
What this trial is testing

A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 231
Large-scale testing (Phase 3)Study completedNCT01564056
What this trial is testing

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

Who this might be right for
Breast Cancer
UNICANCER 1,989
Not applicableUnknownNCT04101656
What this trial is testing

Accelerated Partial Irradiation of the Breast: New Altered Fractionation

Who this might be right for
Breast Cancer
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 174
Testing effectiveness (Phase 2)Study completedNCT02668666
What this trial is testing

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of BreastHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEstrogen Receptor Positive Breast Cancer+2 more
Oana Danciu, MD 49
Testing effectiveness (Phase 2)Study completedNCT00828854
What this trial is testing

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

Who this might be right for
ER+ Breast Cancer
Syndax Pharmaceuticals 27
Testing effectiveness (Phase 2)Looking for participantsNCT06028022
What this trial is testing

Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors

Who this might be right for
Estrogen Receptor-Positive Breast Carcinoma
Mayo Clinic 80
Early research (Phase 1)Study completedNCT02599714
What this trial is testing

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Looking for participantsNCT07287098
What this trial is testing

Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 600
Large-scale testing (Phase 3)Study completedNCT00949598
What this trial is testing

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 177
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105632
What this trial is testing

Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Who this might be right for
Advanced or Metastatic Breast Cancer
Pfizer 333
Large-scale testing (Phase 3)Looking for participantsNCT05512364
What this trial is testing

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

Who this might be right for
ER-positive Breast CancerHER2-negative Breast CancerStage IIB Breast Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 220
Large-scale testing (Phase 3)Looking for participantsNCT06341621
What this trial is testing

Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

Who this might be right for
Breast Cancer
Fudan University 1,900
Testing effectiveness (Phase 2)Study completedNCT00464516
What this trial is testing

Preoperative Estetrol in Breast Cancer

Who this might be right for
Breast Cancer
Pantarhei Bioscience 30
Large-scale testing (Phase 3)Ended earlyNCT01548534
What this trial is testing

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor+1 more
University Hospital, Tours 65
Not applicableNot Yet RecruitingNCT06729099
What this trial is testing

Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients

Who this might be right for
Breast Cancer, Estrogen Receptor-Positive
Assiut University 128
Next Page